Regeneron Pharmaceuticals (REGN)
613.62 -11.98 (-1.91%) 15:03 ET [NASDAQ]
613.07 x 14 614.00 x 14
Realtime by (Cboe BZX)
613.07 x 14 614.00 x 14
Realtime 602.60 -23.00 (-3.68%) 08:49 ET
for Thu, Apr 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 626.25 | 39.09 | 592.20 | ||
| High | 628.00 | 39.18 | 595.46 | ||
| Low | 611.02 | 38.47 | 585.00 | ||
| Last | 613.65 | 38.96 | 589.87 | ||
| Change | -11.95 | +1.32 | +6.25 | ||
| % Change | -1.91% | +3.51% | +1.07% | ||
| Volume | 543,006 | 6,359,588 | 486,288 | ||
| 20-Day Average Volume | 987,817 | 4,829,921 | 372,735 | ||
| Previous Close | 625.60 | 37.64 | 583.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 662.06 | 39.12 | 595.40 | ||
| 20-Day Raw Stochastic | 1.13% | 53.11% | 40.53% | ||
| 20-Day Relative Strength | 36.05% | 56.02% | 44.40% | ||
| Weighted Alpha | -41.33 | -1.92 | +42.33 | ||
| Today's Opinion | 100% Sell | 48% Buy | 8% Sell | ||
| Previous Opinion | 100% Sell | 32% Buy | 8% Sell | ||
| Last Month's Opinion | 88% Sell | 24% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.80% since 03/27/25 | +1.51% since 03/27/25 | -0.77% since 03/27/25 | ||
| Low | 610.10 on 04/02/25 | 37.17 on 04/02/25 | 565.00 on 04/01/25 | ||
| High | 642.97 on 03/28/25 | 39.15 on 04/03/25 | 598.06 on 03/28/25 | ||
| 1-Month | |||||
| %Chg | -10.69% since 03/03/25 | +3.03% since 03/03/25 | -5.41% since 03/03/25 | ||
| Low | 610.10 on 04/02/25 | 37.17 on 04/02/25 | 562.96 on 03/11/25 | ||
| High | 748.29 on 03/10/25 | 40.81 on 03/10/25 | 642.24 on 03/05/25 | ||
| 3-Month | |||||
| %Chg | -14.83% since 01/03/25 | +16.82% since 01/03/25 | -5.21% since 01/03/25 | ||
| Low | 610.10 on 04/02/25 | 31.72 on 01/14/25 | 562.96 on 03/11/25 | ||
| High | 748.29 on 03/10/25 | 40.81 on 03/10/25 | 678.21 on 01/14/25 | ||
| 6-Month | |||||
| %Chg | -39.71% since 10/03/24 | +1.90% since 10/03/24 | +8.46% since 10/03/24 | ||
| Low | 610.10 on 04/02/25 | 31.72 on 01/14/25 | 514.92 on 10/09/24 | ||
| High | 1,024.36 on 10/15/24 | 41.80 on 10/09/24 | 678.21 on 01/14/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 68,393,712 | 77,906,896 | 35,461,336 | ||
| Shares Outstanding, K | 109,325 | 2,069,790 | 60,761 | ||
| Annual Sales | 14,202,000,000 | 40,095,390,000 | 2,252,040,000 | ||
| Annual Net Income | 4,412,600,000 | 3,290,590,000 | 833,040,000 | ||
| Last Quarter Sales | 3,789,200,000 | 10,387,570,000 | 761,220,000 | ||
| Last Quarter Net Income | 917,700,000 | 559,150,000 | 774,160,000 | ||
| 60-Month Beta | 0.44 | 0.56 | 0.60 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 12.07 on 02/04/25 | 0.59 on 02/05/25 | 1.58 on 02/27/25 | ||
| Latest Earnings Date | 04/29/25 | 04/30/25 | 05/08/25 | ||
| Most Recent Dividend | 0.880 on 02/20/25 | 0.393 on 02/21/25 | N/A | ||
| Next Ex-Dividends Date | 02/20/25 | 02/21/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.54 | 9.37 | 238.27 | ||